Patents by Inventor Daqing Sun

Daqing Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200093844
    Abstract: Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
    Type: Application
    Filed: May 9, 2018
    Publication date: March 26, 2020
    Inventors: Xiaohui DU, John EKSTEROWICZ, Valeria R. FANTIN, Erica L. JACKSON, Daqing SUN, Qiuping YE, Jared MOORE
  • Patent number: 10599241
    Abstract: The present disclosure provides a touch panel and a method for manufacturing the same, and a display apparatus. The display panel includes a substrate, a touch electrode provided in a touch region of the substrate, and a plurality of signal transmission lines provided in a non-touch wiring region of the substrate, the non-touch wiring region of the substrate is located in a bezel of the touch panel, the signal transmission lines are coupled to the touch electrode for transmitting a touch signal, the signal transmission lines in the non-touch wiring region are arranged in at least two layers overlapping with each other, and the signal transmission lines of adjacent layers are insulated from each other.
    Type: Grant
    Filed: July 18, 2017
    Date of Patent: March 24, 2020
    Assignees: BOE TECHNOLOGY GROUP CO., LTD., HEFEI XINSHENG OPTOELECTRONICS TECHNOLOGY CO., LTD.
    Inventors: Ning Li, Jianming Jiang, Wei Gu, Tengli Wang, Daqing Sun, Ganlin Ruan
  • Publication number: 20200055892
    Abstract: The present invention relates generally to compositions and methods for treating cancer and hypercortisolism. Provided herein are substituted steroidal derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of glucocorticoid receptors. Furthermore, the subject compounds and compositions are useful for the treatment of cancer.
    Type: Application
    Filed: September 5, 2019
    Publication date: February 20, 2020
    Inventors: Daqing SUN, Lawrence R. McGEE, Xiaohui DU, Liusheng ZHU, Xuelei YAN, Yosup REW, John EKSTEROWICZ, Julio C. MEDINA, Valeria R. FANTIN, Haiying ZHOU, Minna Delarae BALBAS
  • Patent number: 10472387
    Abstract: The present invention relates generally to compositions and methods for treating cancer and hypercortisolism. Provided herein are substituted steroidal derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of glucocorticoid receptors. Furthermore, the subject compounds and compositions are useful for the treatment of cancer.
    Type: Grant
    Filed: March 26, 2019
    Date of Patent: November 12, 2019
    Assignee: ORIC PHARMACEUTICALS, INC.
    Inventors: Daqing Sun, Lawrence R. McGee, Xiaohui Du, Liusheng Zhu, Xuelei Yan, Yosup Rew, John Eksterowicz, Julio C. Medina
  • Publication number: 20190218246
    Abstract: The present invention relates generally to compositions and methods for treating cancer and hypercortisolism. Provided herein are substituted steroidal derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of glucocorticoid receptors. Furthermore, the subject compounds and compositions are useful for the treatment of cancer.
    Type: Application
    Filed: March 26, 2019
    Publication date: July 18, 2019
    Inventors: Daqing SUN, Lawrence R. McGEE, Xiaohui DU, Liusheng ZHU, Xuelei YAN, Yosup REW, John EKSTEROWICZ, Julio C. MEDINA, Valeria R. FANTIN, Haiying ZHOU, Minna Delarae BALBAS
  • Publication number: 20190062276
    Abstract: The present invention provides MDM2 inhibitor compounds of Formula I, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
    Type: Application
    Filed: March 21, 2018
    Publication date: February 28, 2019
    Inventors: Michael D. Bartberger, Ana Gonzalez Buenrostro, Hilary Plake Beck, Xiaoqi Chen, Richard Victor Connors, Jeffrey Deignan, Jason A. Duquette, John Eksterowicz, Benjamin Fisher, Brian M. Fox, Jiasheng Fu, Zice Fu, Felix Gonzalez Lopez De Turiso, Michael W. Gribble, JR., Darin J. Gustin, Julie A. Heath, Xin Huang, XianYun Jiao, Michael G. Johnson, Frank Kayser, David John Kopecky, SuJen Lai, Yihong Li, Zhihong Li, Jiwen Liu, Jonathan D. Low, Brian S. Lucas, Zhihua Ma, Lawrence R. McGee, Joel McIntosh, Dustin L. McMinn, Julio C. Medina, Jeffrey Thomas Mihalic, Steven H. Olson, Yosup Rew, Philip M. Roveto, Daqing Sun, Xiaodong Wang, Yingcai Wang, Xuelei Yan, Ming Yu, Jiang Zhu
  • Publication number: 20190012026
    Abstract: The present disclosure provides a touch panel and a method for manufacturing the same, and a display apparatus. The display panel includes a substrate, a touch electrode provided in a touch region of the substrate, and a plurality of signal transmission lines provided in a non-touch wiring region of the substrate, the non-touch wiring region of the substrate is located in a bezel of the touch panel, the signal transmission lines are coupled to the touch electrode for transmitting a touch signal, the signal transmission lines in the non-touch wiring region are arranged in at least two layers overlapping with each other, and the signal transmission lines of adjacent layers are insulated from each other.
    Type: Application
    Filed: July 18, 2017
    Publication date: January 10, 2019
    Inventors: Ning LI, Jianming JIANG, Wei GU, Tengli WANG, Daqing SUN, Ganlin RUAN
  • Publication number: 20180354918
    Abstract: The present invention provides MDM2 inhibitor compounds of Formula I, or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
    Type: Application
    Filed: July 30, 2018
    Publication date: December 13, 2018
    Applicant: AMGEN INC.
    Inventors: Michael D. BARTBERGER, Hilary Plake BECK, Michael R. DEGRAFFENREID, Brian M. FOX, Felix GONZALEZ LOPEZ DE TURISO, Lisa D. JULIAN, Frank KAYSER, Julio C. MEDINA, Steven H. OLSON, Yosup REW, Philip M. ROVETO, Daqing SUN, Xuelei YAN
  • Patent number: 10013151
    Abstract: The present disclosure discloses a method and a terminal device for adjusting a widget. The method includes: acquiring a size value of the widget on an interface of a terminal device after switching a grid configuration of the interface from a first grid configuration to a second grid configuration; and determining the number of grids occupied by the widget according to size values of each grid in the second grid configuration.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: July 3, 2018
    Assignee: XIAOMI INC.
    Inventors: Weixing Li, Fei Xu, Daqing Sun, Ying Wang
  • Patent number: 9699295
    Abstract: The present disclosure discloses a method for displaying an icon in a terminal device and the terminal device thereof. The method includes monitoring an implementation of an event which controls a display of the icon; determining animation display parameters according to properties of the icon, if the implementation of the event which controls the display of the icon is detected; and controlling the icon to be displayed in an animated manner in accordance with the animation display parameters. The present disclosure provides more enriched display effects of the icon.
    Type: Grant
    Filed: January 13, 2014
    Date of Patent: July 4, 2017
    Assignee: XIAOMI INC.
    Inventors: Fan Jin, Daqing Sun, Ying Wang
  • Publication number: 20170144971
    Abstract: The present invention provides MDM2 inhibitor compounds of Formula I, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 25, 2017
    Applicant: AMGEN INC.
    Inventors: Michael D. BARTBERGER, Ana GONZALEZ BUENROSTRO, Hilary Plake BECK, Xiaoqi CHEN, Richard Victor CONNORS, Jeffrey DEIGNAN, Jason A. DUQUETTE, John EKSTEROWICZ, Benjamin FISHER, Brian M. FOX, Jiasheng FU, Zice FU, Felix GONZALEZ LOPEZ DE TURISO, Michael W. GRIBBLE, Jr., Darin J. GUSTIN, Julie A. HEATH, Xin HUANG, XianYun JIAO, Michael G. JOHNSON, Frank KAYSER, David John KOPECKY, SuJen LAI, Yihong LI, Zhihong LI, Jiwen LIU, Jonathan D. LOW, Brian S. LUCAS, Zhihua MA, Lawrence R. MCGEE, Joel MCINTOSH, Dustin L. MCMINN, Julio C. MEDINA, Jeffrey Thomas MIHALIC, Steven H. OLSON, Yosup REW, Phillip M. ROVETO, Daqing SUN, Xiaodong WANG, Yingcai WANG, Xuelei YAN, Ming YU, Jiang ZHU
  • Patent number: 9593129
    Abstract: The present invention provides MDM2 inhibitor compounds of Formula I, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: March 14, 2017
    Assignee: Amgen, Inc.
    Inventors: Michael D. Bartberger, Ana Gonzalez Buenrostro, Hilary Plake Beck, Xiaoqi Chen, Richard Victor Connors, Jeffrey Deignan, Jason A. Duquette, John Eksterowicz, Benjamin Fisher, Brian M. Fox, Jiasheng Fu, Zice Fu, Felix Gonzalez Lopez De Turiso, Michael W. Gribble, Jr., Darin J. Gustin, Julie A. Heath, Xin Huang, XianYun Jiao, Michael G. Johnson, Frank Kayser, David John Kopecky, SuJen Lai, Yihong Li, Zhihong Li, Jiwen Liu, Jonathan D. Low, Brian S. Lucas, Zhihua Ma, Lawrence R. McGee, Joel McIntosh, Dustin L. McMinn, Julio C. Medina, Jeffrey Thomas Mihalic, Steven H. Olson, Yosup Rew, Philip M. Roveto, Daqing Sun, Xiaodong Wang, Yingcai Wang, Xuelei Yan, Ming Yu, Jiang Zhu
  • Patent number: 9542070
    Abstract: A method for providing an interactive user interface on a mobile terminal having a touch screen, including: displaying a content layer and a background layer corresponding to the content layer; detecting a contact event occurring on the screen of the mobile terminal and obtaining an operation command corresponding to the contact event; and executing an operation according to the obtained operation command; wherein the background layer is located below the content layer and is configured to display a scene as a background; and the content layer is configured to arrange at least a component for user interaction, a preset point of an icon corresponding to the component being set to correspond to a preset position of the content layer, and the preset position of the content layer being set to correspond to a preset position of the scene displayed by the background layer.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: January 10, 2017
    Assignee: Beijing Xiaomi Technology Co., Ltd.
    Inventors: Fei Xu, Fan Jin, Tian Ren, Guangdou Sun, Weixing Li, Daqing Sun, Ying Wang, Cai Zhu, Xiaowei Hu, Bo Yuan
  • Patent number: 9376425
    Abstract: The present invention provides MDM2 inhibitor compounds of Formula I or II, or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: June 28, 2016
    Assignee: Amgen, Inc.
    Inventors: Michael D. Bartberger, Hilary Plake Beck, Xiaoqi Chen, Richard Victor Connors, Jeffrey Deignan, Jason A. Duquette, John Eksterowicz, Brian M. Fox, Jiasheng Fu, Ana Gonzalez Buenrostro, Felix Gonzalez Lopez De Turiso, Darin J. Gustin, Julie A. Heath, Michael G. Johnson, Frank Kayser, David John Kopecky, Yihong Li, Zhihong Li, Zhihua Ma, Joel McIntosh, Julio C. Medina, Jeffrey Thomas Mihalic, Steven H. Olson, Yosup Rew, Philip M. Roveto, Michael J. Schmitt, Daqing Sun, Xiaodong Wang, Malgorzata Wanska, Christine Weathers, Xuelei Yan
  • Publication number: 20160137667
    Abstract: The present invention provides MDM2 inhibitor compounds of Formula I, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
    Type: Application
    Filed: January 27, 2016
    Publication date: May 19, 2016
    Applicant: AMGEN INC.
    Inventors: Michael D. BARTBERGER, Ana GONZALEZ BUENROSTRO, Hilary Plake BECK, Xiaoqi CHEN, Richard Victor CONNORS, Jeffrey DEIGNAN, Jason A. DUQUETTE, John EKSTEROWICZ, Benjamin FISHER, Brian M. FOX, Jiasheng FU, Zice FU, Felix GONZALEZ LOPEZ DE TURISO, Michael W. GRIBBLE, JR., Darin J. GUSTIN, Julie A. HEATH, Xin HUANG, XianYun JIAO, Michael G. JOHNSON, Frank KAYSER, David John KOPECKY, SuJen LAI, Yihong LI, Zhihong LI, Jiwen LIU, Jonathan D. LOW, Brian S. LUCAS, Zhihua MA, Lawrence R. MCGEE, Joel MCINTOSH, Dustin L. MCMINN, Julio C. MEDINA, Jeffrey Thomas MIHALIC, Steven H. OLSON, Yosup REW, Phillip M. ROVETO, Daqing SUN, Xiaodong WANG, Yingcai WANG, Xuelei YAN, Ming YU, Jiang ZHU
  • Patent number: 9296736
    Abstract: The present invention provides MDM2 inhibitor compounds of Formula I, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
    Type: Grant
    Filed: June 26, 2014
    Date of Patent: March 29, 2016
    Assignee: Amgen INC.
    Inventors: Michael D. Bartberger, Ana Gonzalez Buenrostro, Hilary Plake Beck, Xiaoqi Chen, Richard Victor Connors, Jeffrey Deignan, Jason A. Duquette, John Eksterowicz, Benjamin Fisher, Brian M. Fox, Jiasheng Fu, Zice Fu, Felix Gonzalez Lopez De Turiso, Michael W. Gribble, Darin J. Gustin, Julie A. Heath, Xin Huang, XianYun Jiao, Michael G. Johnson, Frank Kayser, David John Kopecky, SuJen Lai, Yihong Li, Zhihong Li, Jiwen Liu, Jonathan D. Low, Brian S. Lucas, Zhihua Ma, Lawrence R. McGee, Joel McIntosh, Dustin L. McMinn, Julio C. Medina, Jeffrey Thomas Mihalic, Steven H. Olson, Yosup Rew, Philip M. Roveto, Daqing Sun, Xiaodong Wang, Yingcai Wang, Xuelei Yan, Ming Yu, Jiang Zhu
  • Publication number: 20160002185
    Abstract: The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
    Type: Application
    Filed: February 18, 2014
    Publication date: January 7, 2016
    Applicant: AMGEN INC.
    Inventors: Michael D. BARTBERGER, Hilary Plake BECK, Michael R. DEGRAFFENREID, Brian M. FOX, Felix GONZALEZ LOPEZ DE TURISO, Lisa D. JULIAN, Frank KAYSER, Julio C. MEDINA, Steven H. OLSON, Yosup REW, Philip M. ROVETO, Daqing SUN, Xuelei YAN
  • Publication number: 20150286356
    Abstract: A method for controlling display of an application interface is provided. The method includes: detecting a first screen-touching operation; detecting a second screen-touching operation after detecting the first screen-touching operation; determining a movement direction and a movement distance of the second screen-touching operation; and causing the display of the application interface to be moved based on the movement direction and the movement distance of the second screen-touching operation.
    Type: Application
    Filed: June 22, 2015
    Publication date: October 8, 2015
    Inventors: Daqing Sun, Cai Zhu, Weixing Li
  • Publication number: 20150143286
    Abstract: There is provided a method for responding to a sliding operation for use in a terminal having a touch screen and operating on an operating system including a system process, an application process, and an interface delivery process, wherein the application process is configured to draw a display content in a size larger than a size of the touch screen. The method includes: when the system process detects the sliding operation, acquiring a sliding distance and a sliding direction of the sliding operation; transmitting the sliding distance and the sliding direction of the sliding operation to each of the application process and the interface delivery process; when the interface delivery process receives the sliding distance and the sliding direction, moving a display window in the sliding direction, according to the sliding distance; and controlling the touch screen to display a display content corresponding to the moved display window.
    Type: Application
    Filed: August 29, 2014
    Publication date: May 21, 2015
    Inventors: Cai Zhu, Weixing Li, Daqing Sun
  • Publication number: 20150113431
    Abstract: The present disclosure discloses a method and a terminal device for adjusting a widget. The method includes: acquiring a size value of the widget on an interface of a terminal device after switching a grid configuration of the interface from a first grid configuration to a second grid configuration; and determining the number of grids occupied by the widget according to size values of each grid in the second grid configuration.
    Type: Application
    Filed: December 30, 2014
    Publication date: April 23, 2015
    Inventors: Weixing Li, Fei Xu, Daqing Sun, Ying Wang